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Dysregulation of the hypothalamic 
pituitary adrenal (HpA) axis and 
cognitive capability at older ages: 
individual participant meta-analysis 
of five cohorts
Michael Gardner  1, Stafford Lightman2, Diana Kuh  3, Hannie Comijs4, Dorly Deeg4, 
John Gallacher  5, Marie-Claude Geoffroy6, Mika Kivimaki  7, Meena Kumari7,8, Chris power9, 
Rebecca Hardy3, Marcus Richards3 & Yoav Ben-shlomo10
evidence on the association between functioning of the hypothalamic pituitary adrenal (HpA) axis and 
cognitive capability at older ages is mixed. We undertook a systematic review (until October 2016) and 
individual participant data (IpD) meta-analysis to test if dysregulation of the HpA axis is associated 
with worse cognitive capability. Five cohort studies were included in the IpD meta-analysis of diurnal 
cortisol patterns with crystallised and fluid cognitive ability. Higher night time cortisol was associated 
with worse fluid ability (standardised coefficient per SD increase −0.063, 95% CI −0.124, −0.002, 
P = 0.04; I2 = 79.9%; age and gender adjusted). A larger diurnal drop was associated with better fluid 
ability (standardised coefficient per SD increase 0.037, 95% CI 0.008, 0.065, P = 0.01; I2 = 49.2%; age 
and gender adjusted). A bigger cortisol awakening response (CAR) was weakly associated with better 
fluid (P = 0.09; I2 = 0.0%; age and gender adjusted) and crystallised (P = 0.10; I2 = 0.0%; age and gender 
adjusted) ability. there is weak evidence that a greater diurnal decline of the HpA axis and a larger CAR 
are associated with improvements in cognition at older ages. As associations are cross-sectional, we 
cannot rule out reverse causation.
Animal1 and human2 studies suggest that changes in the function of the hypothalamic pituitary adrenal (HPA) 
axis are related to functional ageing. HPA axis activates the secretion of glucocorticoids (cortisol in man and cor-
ticosterone in rodents) from the adrenal cortex, in response to stressful stimuli. Glucocorticoids exhibit a charac-
teristic circadian rhythm. In humans, cortisol levels are typically high on waking, reach a peak at 30–45 minutes 
after waking and subsequently decline over the day, reaching a minimum near midnight3. Most studies focus on 
two dynamic measures of HPA activity3: (1) The size of the diurnal drop, that is the difference in the peak levels in 
the morning and nadir levels at night and (2) the cortisol awakening response (CAR) measured as the difference 
between the level on wakening and the level 30 minutes later.
In some rodent studies, aged animals have glucocorticoid levels showing a delayed return to normal levels fol-
lowing a stressful event1. This has been postulated to lead to a positive feedback loop, such that over time there are 
even greater glucocorticoid responses. Due to degenerative changes in the hippocampus, aged rats4 are impaired 
at inhibiting the secretion of glucocorticoids, following a stressful event. Degeneration is exacerbated by the 
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cumulative exposure to glucorticoids and together these effects form the positive feedback loop. The so called ‘glu-
cocorticoid cascade hypothesis’ has also been examined in humans. Such dysregulation of the HPA axis might lead 
to a flatter diurnal pattern in older individuals, as seen in the Whitehall II (WHII) study of British civil servants5.
Flatter diurnal patterns in older individuals have been shown to be associated with poorer cognitive capability6 
as well as other adverse health outcomes such as cardiovascular disease7 and physical capability8. However, there 
is inconsistency in the results of studies assessing the association between cortisol levels and cognitive capability at 
older ages. Whilst some studies suggest that higher morning cortisol is associated with worse cognitive capability9–11, 
other studies have shown little evidence of this12,13. A flatter diurnal drop has been shown to be associated with 
poorer cognitive capability at older ages6,14,15, but many studies do not measure diurnal decline10,13,16.
Part of the inconsistency might be explained by the heterogeneity in the methods to measure cortisol; cortisol 
has been measured in urine17,18, serum13,19 and in saliva6,20. Furthermore, the outcome measures of cognitive 
capability in the literature are heterogeneous including verbal memory, verbal fluency and reasoning, executive 
function, processing speed and object recognition. Additionally, many of the studies use small unrepresentative 
samples21,22. To our knowledge, no systematic review of the literature has been undertaken to examine the asso-
ciation between cortisol levels and cognitive capability at older ages in larger population-representative cohorts.
Our study consists of two parts. First we undertook a systematic review and second, an individual participant 
data (IPD) meta-analysis23 of five cohort studies, as part of the Healthy Ageing across the Life Course (HALCyon) 
programme, to assess the association between measures of cortisol and cognitive capability. We classified cog-
nitive capability into two summary measures: crystallized and fluid ability24. Crystallised intelligence has been 
defined as “a type of broad mental ability that develops through the “investment” of general intelligence into 
learning through education and experience25” and is relatively stable in ageing. Fluid intelligence has been defined 
as: “the ability to solve problems in unfamiliar domains using general reasoning methods26” and is more sensitive 
to age- and morbidity-associate decline”. Our approach has several advantages: (a) greater statistical power to 
detect modest associations; (b) standardising analyses by grouping cognitive capability and covariates in the same 
way across studies; (c) multiple measures of cortisol allowing a detailed characterisation of the association. We 
hypothesised that a lack of diurnal decline and hence higher cortisol levels across the day, reflecting dysregulation 
of the HPA axis, would be associated with worse cognitive capability.
Results
Our literature search identified 16,355 published studies (Fig. 1). Removing duplicate records left abstracts of 
13,749 unique records to be screened. 13,665 studies were excluded based on the title and abstract and a further 
58 studies were excluded following more detailed evaluation. Following these processes, 26 published studies 
were identified to be included in the review6,9–20,27–39. The characteristics of these studies are shown in Table 2. The 
sample sizes varied from 132 to 4,655 subjects. Cognitive capability was measured using a wide range of psycho-
metric tests including composite screening tests, e.g. MMSE, and multiple specific tests e.g. verbal memory, with 
a high risk of a type I error due to multiple hypothesis testing. Most studies reported some association between a 
measure of HPA functioning and some cognitive outcomes but the actual measure varied between studies includ-
ing higher morning cortisol, flatter diurnal drop, lower morning to evening ratio, bigger area under the curve and 
higher evening cortisol. In some cases, these measures were related to cognition only in sub-groups e.g. APOE-ε4 
carriers. Since the outcome measures of cognitive capability across these 26 studies were heterogeneous, a formal 
meta-analysis of these studies was not justified (Table 2).
Descriptive characteristics of the five studies included in the individual-participant data meta-analysis are 
shown in Table 3. Age range was from 50 to 88 years, the youngest cohort being NCDS (50.7 ± 0.15 SD years) 
and the oldest LASA (75.1 ± 6.4 SD years). There was some variation of the same crystallised and fluid cognition 
measures between studies, in part due to differences in test protocols. Mean NART totals were 28.0 ± 11.1 SD 
in CaPS and 35.9 ± 8.8 SD in NSHD. Verbal fluency ranged from 15.6 ± 3.8 SD in WHII to 22.6 ± 6.2 SD in 
NCDS. Verbal and mathematical reasoning was 26.3 ± 10.4 SD in CaPS and 44.2 ± 10.9 SD in the younger WHII 
cohort. Reaction time was 0.69 ± 0.20 SD seconds in CaPS and 0.62 ± 0.09 SD seconds in NSHD. Verbal memory 
(AVLT) ranged from 6.9 ± 2.4 SD in WHII to 24.8 ± 5.8 SD in NSHD, although there were variations in the tests. 
Processing speed was 265.5 ± 69.9 SD in NSHD and 335.8 ± 88.2 SD in NCDS.
Individual-participant data meta-analyses. Total sample size in the age and sex-adjusted models varied 
between 5,131 and 12,143 depending on the meta-analysis (Table 4). Associations between the cortisol measures 
and crystallised and fluid ability from fixed or random effects meta-analyses were as follows: (a) Crystallised 
ability - bigger CAR (Table 4; Fig. S1d) was weakly associated with a better crystallised ability when age and 
gender adjusted (P = 0.10; I2 = 0.0%, P = 0.74) and this was little changed after further adjustments for BMI, 
smoking and socioeconomic position (P = 0.06; I2 = 0.0%, P = 0.93). No association was found between the other 
cortisol measures and crystallised ability (Table 4; Fig. S1). (b) Fluid ability - higher night time cortisol (Table 4; 
Fig. 2) was associated with a worse fluid ability (P = 0.04; I2 = 79.9%, P = 0.01) when age and gender adjusted, 
although this association was attenuated after adjusting for BMI, smoking and socioeconomic position (P = 0.10; 
I2 = 63.2%, P = 0.07). A larger diurnal drop (Table 4; Fig. 3) was associated with better fluid ability when age and 
gender adjusted (P = 0.01; I2 = 49.2%, P = 0.12), although this was again attenuated when further adjusting for 
BMI, smoking and socioeconomic position (P = 0.25; I2 = 61.3%, P = 0.05). A bigger CAR (Table 4; Fig. S2b) was 
weakly associated with a better fluid ability whether age and gender adjusted (P = 0.09; I2 = 0.0%, P = 0.43) or 
after additional adjustments for BMI, smoking and socioeconomic position (P = 0.07; I2 = 0.0%, P = 0.61).
Heterogeneity and meta-regression analyses. There was evidence of heterogeneity between studies 
in age and sex-adjusted meta-analyses ranging from low (I2 = 0%, P = 0.43) for the associations between CAR 
and fluid ability to high (I2 = 80.0%, P = 0.001) for the associations between morning cortisol and fluid ability. 
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In meta-regression analyses, there was no strong evidence that the associations between the various cortisol 
measures and either crystallised or fluid ability differed by age (above and below median), gender, BMI (obese 
or non-obese), smoking status (current smoker versus non-smoker) or socioeconomic position (higher versus 
lower socioeconomic position). There was weak evidence to suggest that the associations were stronger in obese 
than non-obese participants for night time cortisol and crystallised ability but this could have been due to chance 
(F = 4.64, P = 0.10). Furthermore, there was evidence to suggest that the associations were stronger in partici-
pants from lower versus higher socioeconomic position for diurnal drop and crystallised (F = 3.71, P = 0.13) or 
fluid ability (F = 12.60, P = 0.02). However, the former could have been due to chance and the latter due to a type 
1 error (multiple testing).
sensitivity analyses. Re-running analyses using fixed-effect meta-analyses rather than random-effects 
meta-analyses had little effect on the associations (data not shown). We found little effect on the meta-analysis for 
the associations between diurnal drop and fluid ability when we omitted the NCDS cohort data. A larger diurnal 
drop was associated with better fluid ability when NCDS cohort was omitted (standardised coefficient per SD 
increase 0.048, 95% CI 0.016, 0.080, P < 0.01; age and gender adjusted), as we found when NCDS cohort was 
included (standardised coefficient per SD increase 0.037, 95% CI 0.008, 0.065, P = 0.01; age and gender adjusted).
We found little effect on the meta-analyses for the associations between morning cortisol and i) crystallised ability 
(standardised coefficient per SD increase 0.008, 95% CI −0.042, 0.057, P = 0.74; age and gender adjusted) and 
ii) fluid ability (standardised coefficient per SD increase 0.05, 95% CI −0.037, 0.046, P = 0.83; age and gender 
adjusted) when we omitted the LASA cohort data. Re-running analyses using a Restricted Maximum Likelihood 
(REML) method rather than the DerSimonian-Laird random-effects method had little effect on the associations 
(data not shown).
Discussion
Twenty six published observational studies were identified in our systematic review. Many of these found some 
association between cortisol and various cognitive outcomes, but since outcome measures of cognitive perfor-
mance across these studies were heterogeneous, we did not carry out a meta-analysis of these studies. It is difficult 
to assess how much of the effects seen across these heterogeneous studies with some positive findings reflect a true 
causal association, or associations secondary to confounding, reverse causation, type I errors and publication bias. 
For our IPD meta-analysis, we found that higher night time cortisol was associated with worse fluid ability after 
adjustment for age and gender (high heterogeneity). A larger diurnal drop in cortisol was associated with better 
fluid ability (moderate heterogeneity). These associations were attenuated after adjustment for BMI, smoking and 
Figure 1. Flow diagram for identification of published studies for inclusion in review.
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socioeconomic position. A larger CAR was weakly associated with better fluid (low heterogeneity) and crystallised 
capability (low heterogeneity), but no associations were found between morning cortisol, night time cortisol or 
diurnal drop and crystallised capability. We decided to adjust our associations for BMI as a measure of adiposity 
but whether adiposity is secondary to a less dynamic HPA axis40 or vice versa is unclear41. Our BMI-adjusted anal-
yses might be over adjusted if BMI acts as an intermediary in the pathway between cortisol and cognitive capability.
Our findings are in agreement to some degree with the results of studies assessing the cross-sectional asso-
ciations between cortisol levels and cognitive performance at older ages (Table 2). Higher night time cortisol 
has been shown to be associated with poorer cognitive performance at older ages34,36, although other studies 
have found little evidence of such an association39. A larger diurnal drop has been shown to be associated with 
better cognitive performance at older ages6,15, although many studies did not measure diurnal decline (Table 2). 
Our results showed that a larger CAR was weakly associated with better fluid and crystallised capability. In the 
Vietnam Era Twin Study of Aging (VETSA)33, a larger CAR was associated with poorer cognitive performance, 
although this association was attenuated after adjusting for area under the curve (AUC). Many studies however, 
did not measure CAR (Table 2). Our results showed little evidence of an association between morning cortisol 
and cognitive performance, in agreement with some of the literature12,13; however, several studies have shown that 
higher morning cortisol is associated with worse cognitive performance (e.g.11,35; Fig. S1a; LASA cohort).
Fluid ability CaPS LASA NCDS NSHD Whitehall II
Verbal fluency 
(Animal Naming)
Participants name as many 
animals as possible in 
60 seconds.
Participants name as 
many animals as possible 
in 60 seconds.
Participants name as 
many animals as possible 
in 60 seconds.
Verbal Memory
(a) AVLT is a test of verbal 
memory10, based on list learning. 
In LASA 15 words were learned in 
each of three trials and the learning 
score was the total number of words 
learned (maximum 45).
(b) The Coding Task measures 
verbal associative memory10. Here, 
two rows paired characters are 
shown, each character in the upper 
row belonging to a character in the 
bottom row. The participant was 
then offered one character and had to 
verbally mention the missing paired 
second character. The participant 
had to complete as many character 
combinations as possible in one 
minute and the mean score for the 
three trials was used in the analyses.
(c) Immediate Verbal 
Memory by Immediate 
Memory recall task11. This 
was measured by how 
many words a participant 
could recall from a list 
of 10 common words 
immediately after the 
word list was read.
(a) AVLT is a test of verbal 
memory, based on list 
learning. In NSHD 15 words 
were learned in each of three 
trials and the learning score 
was the total number of words 
learned (maximum 45).
(a) AVLT is a test of 
verbal memory, based 
on list learning. In WHII 
participants were shown 
a list of 20 one or two-
syllable words at 2- second 
intervals and asked to 
recall as many words in 
writing within 2 minutes.
Processing 
Speed (Letter 
cancellation task)
Letter Cancellation11
Participants were 
presented with a page 
containing 125 upper-case 
letters of the alphabet, 
of which 65 were target 
letters (P and W) and 
had to cross out as many 
target letters as possible in 
1 minute.
Letter Cancellation72
Participants were presented 
with a page containing 125 
upper-case letters of the 
alphabet, of which 65 were 
target letters (P and W) and 
had to cross out as many 
target letters as possible in 
1 minute.
Reaction Time
A choice reaction time task 
with a visual signal was used. 
Participants pressed one of 
four buttons as quickly as 
possible corresponding to 
which of the numbers 1 to 4 
appeared in the signal screen.
A choice reaction time task 
with a visual signal was used. 
Participants pressed one 
of four buttons as quickly 
as possible corresponding 
to which of the numbers 1 
to 4 appeared in the signal 
screen. Eight practice trials 
were given, followed by 40 
real trials.
Verbal and 
mathematical 
reasoning (Alice 
Heim Test)
Alice Heim test is made up 
of 65 items (33 mathematical 
reasoning and 32 verbal 
reasoning) of increasing 
difficulty. Participants identify 
patterns and infer principles 
and rules.
Alice Heim Test73
Made up of 65 items (33 
mathematical reasoning 
and 32 verbal reasoning) 
of increasing difficulty. 
Participants identify 
patterns and infer 
principles and rules.
Non verbal 
reasoning 
(Raven’s 
Coloured 
Progressive 
Matrices- RCPM)
In RCPM61, the ability to deal with 
new information was measured by 
two subsets of 12 items (A and B). 
Each item consisted of drawing of 
a pattern with a section missing. 
Participants chose which of six 
patterns fitted the missing section. 
The items increased in difficulty and 
the maximum score was 24.
Table 1. Fluid ability measures.
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There are several potential explanations for the inconsistencies in the literature. First, cortisol has been 
measured using average cortisol measures such as urinary cortisol3, or has been measured only in a morning 
serum sample. Second, many of the studies in the literature use small unrepresentative samples e.g.21,42. Third, 
the outcome measures of cognitive performance in the literature are heterogeneous and include verbal mem-
ory and verbal fluency6, executive function33, processing speed15 and object recognition30. Hence we classified 
cognitive performance into crystallized intelligence (stable in maturity and representing the investment of 
general intelligence into skills, knowledge, and experience) and fluid intelligence (more vulnerable to age- and 
Author Cohort Cortisol measure Outcome Measure
Strongest Predictor  
(of worse cognition)
Alfaro et al.16 313 women and men 71–102 years morning serum MMSE
higher morning cortisol 
(women) cross-sectional
Beluche et al.6 197 women and men 65–90 years
saliva 3 times over day 
repeated next day
Verbal/visual memory,verbal fluency Cross-
sectional and change
flatter diurnal drop 
longitudinal
Berteau-Pavy et al.30 116 women and men 62–92 years saliva 8.30 am
Facial/Face/Object recognition Reaction time, 
Memory Island, MMSE
higher morning cortisol 
(men) cross-sectional
Comijs et al.10 1154 women and men 65–88 years serum before 10 am
MMSE, AVLT, Coding Task Cross-sectional 
and change
higher morning cortisol 
cross-sectional
Fiocco et al.32 106 women and men 57.9 ± 0.40SE years saliva 5 times over day Declarative memory No association
Fonda et al.12 1156 men 48–80 years 2 morning serum Working memory, speed/attention spatial ability No association
Franz et al.33 778 men 51–60 years saliva 5 times over day repeated 3 separate days
General cognitive ability Neurocognitive 
battery including: Verbal memory, executive 
functioning
area under the curve 
cross-sectional
Gaysina et al.20 1796 women and men 60–64 years saliva 4 times over day
Verbal memory Letter search speed, reaction 
time
higher evening cortisol 
cross-sectional
Geerlings et al.36 4244 women and men 44–45 years 76 ± 5SD years
morning and evening 
salivary cortisol Memory, speed Executive functioning
higher evening cortisol 
cross-sectional
Geoffroy et al.11 4655 women and men 2 morning saliva Verbal memory, verbal fluency Speed of processing
higher late morning 
cortisol longitudinal
Gerritsen et al.15 911 women and men 75.5 ± 6.8SD years saliva 2 times over day
Global cognitive functioning Verbal memory, 
processing speed Baseline and at 4 years 
follow-up
flatter diurnal drop 
(APOE-ε4 carriers) 
longitudinal
Greendale et al.19 749 women 72.0 ± 8.1SD years morning serum
Visual reproduction, MMSE Trails B, Category 
Fluency Cross-sectional and change
higher morning cortisol 
longitudinal
Johar et al.37 599 women and men 65–90 years saliva 3 times over day
TICS-m with 4 domains: Orientation; memory; 
Attention/calculation and language
Lower morning to evening 
cortisol ratio (men) cross-
sectional
Kalmijn et al.28 189 women and men 55–80 years serum 8–9 am MMSE Cross-sectional and change
Higher morning cortisol 
cross-sectional
Karlamanga et al.18 538 women and men 70–79 years urinary 8 pm-8 am
Mental status questionnaire Cross-sectional 
and change
Higher overnight urinary 
cortisol longitudinal
Kuningas et al.9 563 women and men 85 years serum before 11am MMSE, speed, attention, recall Cross-sectional and change
Higher morning cortisol 
longitudinal
Lee et al.31 1140 women and men 50–70 years saliva 4 times over day
Language, executive function Verbal/visual 
memory, speed
area under the curve 
cross-sectional
Mora et al.35 313 women and men 76.7 ± 7SD years morning serum MMSE Baseline and at 2 years follow-up
Higher morning cortisol 
(women) cross-sectional
O’ Hara et al.14 154 women and men 60–100 years saliva 5 times over day MMSE, speed, spatial verbal memory
flatter diurnal drop cross-
sectional
Schrijvers et al.13 3341 women and men 72.0 ± 6.8SD years morning serum
MMSE and Test Battery: Executive function, 
attention and Information processing 
speedInformation processing speed Baseline 
and 7 years mean follow-up
No association
Seeman et al.17 200 women and men 70–79 years urinary 8 pm-8 am
Recall, spatial verbal memory Cross-sectional 
and change
Higher overnight 
urinary cortisol (women) 
longitudinal
Segerstrom et al.38 132 women and men 60–93 years saliva 3 times over day
Verbal memory, executive function Cros-
sectional and change
area under the curve 
longitudinal
Singh-Manoux et al.27 3229 women and men 61 years saliva 6 times over day
Verbal memory, verbal fluency and Reasoning 
Baseline and 5 years mean follow-up
Flatter diurnal slope 
Higher night time cortisol 
in APOE-ε4 carriers 
longitudinal
Stawski et al.34 1500 women and men 33–84 years
saliva 4 times over day On 
4 consecutive days
BTACT with fluid domains: Verbal memory, 
reasoning, working memory span, Executive 
functioning and processing speed
Higher night time cortisol 
cross-sectional
Stomby et al.39 200 women and men 55–80 years saliva 4 times over day
Episodic memory, semantic memory, 
Visuospatial ability, working memory No association
Wright et al.29 133 women and men 65–80 years saliva 8 times over day Declarative memory, matrix reasoning
cortisol response cross-
sectional
Table 2. Characteristics of studies included in the review.
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morbidity-associated decline, and concerned with reasoning and on the spot problem solving in novel situa-
tions24). We note however, that heterogeneity in our IPD meta-analyses ranged from low to high. Fourth, cortisol 
is secreted in a pulsatile manner43. This means that single samples are not representative of average levels at any 
particular time and multiple samples would be needed to really understand cortisol concentrations at any one 
time. Frequently therefore there is considerable measurement error in characterising the HPA axis and for CAR 
for instance, it has been recommended that CAR be performed at least twice on two separate days44.
Several longitudinal studies have investigated the association between cortisol and cognitive performance 
(Table 2). Higher urinary cortisol measures at baseline have been associated with poorer cognitive performance at 
follow-up17,18. Studies of the association between morning serum cortisol at baseline and cognitive performance 
at follow-up are contradictory (Table 2). These longitudinal studies did not have measures of diurnal cortisol pro-
files and in the Whitehall II study27, there was little evidence of a longitudinal association between diurnal cortisol 
patterns and cognitive performance. This cohort study of civil servants does not include blue collar workers or 
unemployed people limiting its generalisability. In the Longitudinal Aging Study Amsterdam (LASA)15, lower 
morning cortisol, higher night time cortisol levels and flatter diurnal slope, were associated with increased risk 
of memory decline in APOE-ɛ4 carriers but not in non-carriers, and this sub-group analysis needs replication. 
Inconsistent associations are elegantly demonstrated in a study of community dwelling older participants6, which 
found that a flatter diurnal slope was associated with decline in visuo-spatial performance and visual memory 
Variable CaPS LASA NCDS NSHD Whitehall II
N 771 1151 4824 1165 2936
Gender (% male) 100 48.7 51.7 45.4 75.3
Age (years) 73.2 (4.0) 75.1 (6.4) 50.7 (0.15) 63 61.1 (5.9)
BMI (Kg/m2) 27.8 (3.9) 26.9 (4.2) 27.3 (4.8) 27.9 (4.8) 26.7 (4.3)
Current smoker (%) 13.6 18.1 17.9 16.5 7.8
Lower SEP (%) 60.4 39.9 33.4 25.2 53.5
Serum morning cortisol (nmol/L) — 497.9 (170.8) — — —
Salivary cortisol (nmol/L)
T1 morning 19.6 (10.1) — 21.2 (11.2) 23.4 (9.8) 20.0 (8.1)
T2 3.6 (5.5) — 8.3 (7.1) 3.2 (3.4) 2.4 (2.7)
Crystallised ability
NART 28.0 (11.1) — — 35.9 (8.8) —
Mill Hill — — — — 25.1 (4.2)
GIT vocabulary test — 12.9 (4.0) — — —
Fluid ability
Verbal fluency 17.7 (5.0) — 22.6 (6.2) — 15.6 (3.8)
Verbal Memory
(i) AVLT — 19.5 (6.2) — 24.8 (5.8) 6.9 (2.4)
(ii) Coding Task — 23.4 (7.1) — — —
(iii) Immediate memory — — 6.7 (1.5) — —
Processing Speed — — 335.8 (88.2) 265.5 (69.9) —
Reaction Time (s) 0.69 (0.20) — — 0.62 (0.09) —
Verbal and mathematical reasoning 26.3 (10.4) — — — 44.2 (10.9)
Non verbal reasoning — 17.3 (4.5) — — —
Table 3. Characteristics of the participants aged 50–88 years, by study. Results are presented as mean (SD), 
unless otherwise stated and are complete data including confounders and morning and night time cortisol 
measures (where available) and crystallised and fluid cognitive capability. Serum cortisol level is a morning 
sample in LASA. T1 salivary morning cortisol in CaPS, NSHD and Whitehall II was computed as the mean 
of the waking and 30 minute samples. In NCDS T1 was the 45 minutes after waking sample. In CaPS, NSHD 
and Whitehall II T2 was the night time cortisol sample and in NCDS it was the 3 hours 45 minutes after 
waking sample. See methods for detailed descriptions of crystallised capability and fluid cognition measures. 
Crystallised capability is the National Adult Reading Test (NART) (0–50) in CaPS and NSHD, the Mill Hill 
Vocabulary Test (0–33) in Whitehall II and the GIT-vocabulary test in LASA. Fluid capability is derived by 
factor analysis of the fluid cognition measures in each of the cohorts. Fluid cognition measures in CaPS are 
animal naming, Alice Heim test (AH4) and reaction time (loge); Coding task, Auditory Verbal Learning Test 
(AVLT) or Verbal Memory and Ravens Coloured Progressive Matrices (RCPM) in LASA; Verbal memory (15 
item word recall over 3 trials), search speed (0–600) and choice reaction time in NSHD and animal naming, 
verbal memory (20 item word recall) and AH4 in Whitehall II. Across the cohorts, there was no standard 
method for classifying socioeconomic position. In CaPS, NCDS and NSHD, lower socioeconomic position was 
classified as manual (skilled manual, semi-skilled manual and unskilled) and higher socioeconomic position 
as non-manual (professional, managerial or skilled non-manual). In LASA, lower socioeconomic position was 
classified as low education level attained and higher socioeconomic position as middle and high education 
level attained. In Whitehall II, lower socioeconomic position was employment grade 1 and 2 and higher 
socioeconomic position was employment grade 3.
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in men but in verbal fluency in women. In one small cohort study, higher event-based stress was associated with 
faster cognitive decline45 only in subjects with cognitive impairement at baseline and paradoxically higher mean 
daily cortisol in this sub-group was associated with slower decline.
One approach to examine the HPA dysfunction hypothesis is to look at cognition in patients with Cushing’s 
syndrome, who have chronic exposure to elevated levels of cortisol. This syndrome has been associated with defi-
cits in several areas of cognitive performance, including non-verbal memory and visual and spatial information46. 
For both patients with Cushing’s syndrome47 and in older adults48, exposure to high cortisol levels has been shown 
to be associated with a smaller volume of the hippocampus. Such findings might subsequently lead to hippocam-
pal atrophy1. However, in a recent study39, higher area under the daytime cortisol curve (AUC- average cortisol 
across the day) was not associated with hippocampal volume, but was inversely associated with prefrontal cortical 
surface area and with prefrontal cortical thickness.
The key strength of this pooled analysis is that it is based on five adult cohort studies with a large combined 
sample size (ranging from n = 5,131 to 12,143 participants). We undertook a 2-step IPD meta-analysis23 which 
provided greater statistical power to detect modest associations and enabled us to standardise analyses by group-
ing cognitive performance and covariates in the same way across studies. We classified cognitive performance into 
Outcome and cortisol 
measure
Model A Model B (Fully Adjusted)
(Age, sex adjusted) (Age, sex, BMI, smoking status, socioeconomic position)
β† 95% CI P-value I2 P-value‡ β† 95% CI P-value I2 P-value‡
Crystallised ability (sd score)
Morninga (n = 6775) −0.005 −0.050, 0.040 0.83 71.6% 0.01 −0.003 −0.034, 0.028 0.83 47.5% 0.13
Night timeb (n = 5285) −0.021 −0.068, 0.026 0.39 65.3% 0.06 −0.007 −0.048, 0.035 0.75 59.6% 0.08
Diurnal dropc (n = 5131) 0.021 −0.033, 0.076 0.44 72.8% 0.03 0.010 −0.024, 0.045 0.56 40.2% 0.19
CARd (n = 5159) 0.021 −0.004, 0.046 0.10 0.0% 0.74 0.023 −0.001, 0.047 0.06 0.0% 0.93
Fluid ability (sd score)
Morninga (n = 12143) −0.008 −0.049, 0.032 0.69 80.0% 0.001 −0.007 −0.041, 0.027 0.68 73.1% 0.01
Night timeb (n = 5276) −0.063 −0.124, −0.002 0.04 79.9% 0.01 −0.036 −0.080, 0.008 0.10 63.2% 0.07
Diurnal dropc (n = 10497) 0.037 0.008, 0.065 0.01 49.2% 0.12 0.019 −0.013, 0.051 0.25 61.3% 0.05
CARd (n = 5136) 0.022 −0.003, 0.047 0.09 0.0% 0.43 0.022 −0.001, 0.046 0.07 0.0% 0.61
Table 4. Overall summary estimates of effect for the associations between cortisol measures and cognitive 
capability from fixed or random effects meta-analyses. N = Sample size in age and sex adjusted analyses; 
† Differences in standardised crystallised ability; Differences in fluid ability; ‡ P-value is obtained from the 
heterogeneity χ²; aMorning salivary cortisol is the average of the mean waking and 30 minutes post wakening 
samples in CaPS, NSHD and Whitehall II and in LASA, morning (before 10am) serum cortisol samples were 
taken; bNight time cortisol in CaPS, NSHD and Whitehall II was transformed (loge); cDiurnal drop is the 
difference between morning and night time salivary cortisol; dCAR is the difference between the 30 min. post 
waking sample and the waking sample; All cortisol measures have been z-scored. Random effects meta-analyses 
were for I2 ≥40.2%, otherwise fixed effect meta-analyses were used.
Figure 2. Meta-analysis for the association between night time cortisol and fluid cognitive ability adjusted for 
age and sex.
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crystallized and fluid capability to reduce multiple testing and enable standardization across cohorts. Even with 
this approach, there was statistical evidence of between studies heterogeneity (I2 varying between 49.2% to 80%) 
and we did not find many factors which explained this heterogeneity, although we were probably underpowered 
for this. Alternatively to increase the power of the analyses, multivariate meta-analyses49 might be undertaken in 
future studies. Whilst we observed some heterogeneity of effects with the CAR measures, we acknowledge that 
the outcomes we derived within each study may violate the assumption of measurement invariance and this may 
introduce artefactual heterogeneity. Our measures of the HPA axis will have measurement error, particularly for 
those studies using a single serum cortisol measure (i.e. LASA) and measures made on multiple days are recom-
mended44. In line with current guidelines50, we recommend that future studies on CAR use objective methods 
for verification of awakening times, such as polysomnography or wrist actigraphy. We could not exclude reverse 
causation, given our cross-sectional data. This is highlighted in the Vietnam Era Twin Study of Aging33 where 
worse cognitive performance at age 20 predicted elevated midlife cortisol and a smaller diurnal drop in midlife, 
and also by previous research on the NCDS suggesting that cortisol-cognitive performance associations at older 
ages may be due, in part, to associations from earlier in life i.e. with childhood cognition11. Our selection of 
cohorts may also be criticised as they spanned a range of birth cohorts that were predominantly from the United 
Kingdom which limits their generalizability.
In conclusion, we did not find any evidence to suggest strong associations between HPA dysfunction and 
worse cognition, but there was some evidence that a more responsive HPA axis is associated with better cognitive 
performance in later life. However, these are modest associations and, furthermore, are cross-sectional in nature 
so reverse causation cannot be ruled out. We would recommend that future studies either use some form of mul-
tiple sampling technology or at least collect both morning and night time samples, for several days, and look into 
associations between change in cortisol and change in cognitive performance to help untangle causality.
Methods
We undertook a systematic review of the published literature following the meta-analysis of observational studies 
in epidemiology (MOOSE) guidelines51 and the PRISMA statement52.
selection criteria. Eligible observational studies were those conducted on individual participants that exam-
ined the association between measures of diurnal cortisol patterns and cognitive capability. Eligible study popu-
lations were community dwelling older adults, identified in titles and/ or abstracts. Eligible studies had to have a 
minimum number of 100 participants and we excluded studies of patient or disease-selected groups e.g. diabetic 
patients.
Literature search and additional studies. Searches of the electronic databases MEDLINE and EMBASE 
(from 1950 or 1980 up to 25th October 2016) were performed using text word search terms and explosion MeSH 
terms (Supplementary Methods) by MG. Initially we had aimed to undertake a data extraction from the sys-
tematic review of the literature and combine the results with the individual participant data from the HALCyon 
cohorts. Since the outcome measures of cognitive capability across these 26 studies were heterogeneous, a formal 
meta-analysis of these studies was not justified. We did not undertake a data extraction, or assess the quality of 
each study, but we did summarise the characteristics of these studies.
Figure 3. Meta-analysis for the association between diurnal drop and fluid cognitive ability adjusted for age 
and sex.
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the cohorts. The HALCyon research programme on cortisol and ageing outcomes involves nine UK 
cohort studies. Three of these cohorts have data on both cortisol and cognitive capability: the Caerphilly 
Prospective Study (CaPS)53; the 1958 British Birth Cohort (NCDS)11,54; the MRC National Survey of Health and 
Development20,55. We have additionally included two large-scale cohort studies identified through the HALCyon 
collaboration: the Longitudinal Ageing Study Amsterdam (LASA)15,56 and the Whitehall II (WHII) study27,57. 
Details of the cohorts are given in Supplementary Methods.
Cortisol measures. In LASA, morning (before 10am) serum cortisol samples were taken in cycle 2 (age 
64–88 years) and the serum levels were determined using a competitive immunoassay10. The inter-assay and 
intra-assay coefficients of variation were below 8% and 3% respectively.
Salivary cortisol samples were collected in CaPS (age 65–83 years), NCDS (age 44–45 years), NSHD (age 60–64 
years) and WHII (age 50–73 years). Participants were shown how to collect saliva using plain cotton wool swabs 
(salivettes) at home. Participants were asked to chew on the salivettes for one to two minutes and a saliva sample 
was obtained. In CaPS, participants took samples on waking, 30 minutes after waking, at 2 pm and at 10 pm over 
two consecutive days. In NCDS, samples were taken 45 minutes after waking (T1) and 3 hours later (T2). In NSHD 
samples were taken on waking, 30 minutes after waking and at 9 pm. A mid-morning sample was also taken in 
NSHD at the clinic visit but has not been used in this analysis. In WHII, samples were taken on waking, 30 minutes 
after waking and at waking +2.5 h, +8 h, + 12 h and at bedtime. Samples were frozen and subsequently assayed by 
chemiluminescence. In CaPS, NSHD and WHII morning salivary cortisol was computed as the mean of waking 
and 30 minute samples. In NCDS, the 45 minutes after waking sample was used as the morning salivary cortisol 
sample (T1). In each of CaPS, NCDS, NSHD and WHII assays were done in the same laboratory (Dresden) special-
ising in high through-put cortisol assays58. In CaPS, the inter-assay coefficient of variation for the salivary cortisols 
was 4% at both low (5.3nmol/l) and high controls (39.0nmol/l)59. The inter-assay and intra-assay coefficients of 
variation were less than 10% in NCDS11, less than 6% in NSHD and less than 8% in WHII5.
Cognitive capability measures. Crystallised and fluid ability measures were taken in CaPS (age 65–83 
years), LASA (age 64–88 years), NCDS (age 50 years) and WHII (age 50–73 years). In NSHD, crystallised ability 
measures were taken at age 53 and fluid ability measures were taken at age 62–65 years.
Crystallised ability. In CaPS and NSHD the crystallised capability measure was the National Adult Reading Test 
(NART)60, a word pronunciation test with maximum score 50, highly correlated with general cognitive ability. In 
Whitehall II, the Mill Hill Vocabulary test61 encompassed the ability to recognise and comprehend words, consist-
ing of a list of 33 stimulus words of increasing difficulty and six response choices per word. In LASA, crystallised 
intelligence was measured by the Groninger Intelligentie Test (GIT)62. Here, 20 words of increasing difficulty are 
presented and the participant chooses a synonym from five alternatives and the maximum score is 20. In NSHD, 
the NART score was taken at age 53, which is the only cohort where the crystallised capability measure predated 
the cortisol measure.
Fluid ability. The fluid ability measures for each cohort are detailed in Table 1. We derived one fluid capability 
measure per cohort and these details are given in the statistical analyses section.
Clinical and questionnaire-based data. Anthropometric measures were taken at clinic (CaPS, NSHD 
and WHII) or by medical interview at home (NCDS and LASA). Standard height was measured to the nearest 
mm using a stadiometer. Weight was measured in Kg using standardised scales (CaPS and NSHD), a SECA floor 
scale (LASA), Tanita solar scales (NCDS) or by an electronic Soehule scale (Leifheit AS) with a digital readout 
(WHII). Body Mass Index (BMI) was calculated as weight divided by height2 (Kg/m2). Smoking behaviour was 
assessed by self-completed questionnaire (CaPS, NCDS and WHII) or medical interview (LASA and NSHD). 
The derived variable for smoking status was classified into never, past or current. Across the cohorts there was 
no standard method for classifying socioeconomic position (SEP). In CaPS, NCDS and NSHD, SEP was defined 
by the British Registrar General’s classification of occupation and based on own occupation in adult life. The 
grouping was I or II (professional/managerial), IIINM (skilled non-manual), IIIM (skilled manual) and IV and 
V (semi-skilled and unskilled manual). In CaPS SEP was measured at phase 2, in NCDS at age 42 years and in 
NSHD at age 53. Lower SEP was classified as manual and higher SEP as non-manual. In LASA, SEP was defined 
according to education level attained62. Lower SEP was classified as low education level attained (elementary not 
completed and elementary education) and higher SEP as middle (including intermediate vocational education 
and general secondary education) and high (including college education and university) education level attained. 
In WHII, SEP at phase 7 was defined according to last known employment grade, where lower SEP was employ-
ment grade 1 and 2 and higher SEP was employment grade 3.
statistical analyses. Since cortisol has a marked circadian rhythm, we adjusted for times of sampling in 
CaPS, NCDS, NSHD and WHII, the cohorts with measures of salivary cortisol. In CaPS, NSHD and WHII, data 
on the actual times at which salivary cortisol samples were taken were available. In CaPS, NSHD and WHII we 
fitted a linear or polynomial function to the association between cortisol and time of measurement and when 
time of sampling predicted cortisol levels, we added residuals from the best fit model to the overall mean corti-
sol value53. To take into account time of sampling in NCDS, cortisol values for each individual were centred at 
45 minutes after the mean waking time and at 3 hours 45 minutes after the mean waking time11. In addition to 
the morning (CaPS, LASA, NCDS, NSHD and WHII) and night time (CaPS, NSHD and WHII) samples, we 
derived the diurnal drop in CaPS, NCDS, NSHD and WHII. In CaPS, NSHD and WHII this was the difference 
between the morning and evening salivary cortisol samples. In NCDS, the diurnal drop was (T1 − T2)/3. We 
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z-scored each of the cortisol measures including morning cortisol and night time cortisol, as well as the derived 
diurnal drop measure. In CaPS, NSHD and WHII, we also calculated the ‘Cortisol Awakening Response’ (CAR) 
(difference between the 30 minutes post waking sample and the waking sample). We also z-scored the derived 
CAR measure. We excluded participants treated by oral corticosteroid medication and in WHII we excluded 
participants who took samples later than 10 minutes after waking.
Whilst free cortisol concentrations are found in saliva, in serum cortisol levels represent total protein bound 
and free cortisol concentrations. In a study investigating the association between serum and salivary cortisol 
levels in healthy individuals63, correlations were high. We converted absolute cortisol levels to study- specific 
z-scores (mean 0 and standard deviation 1). Night time cortisol was positively skewed and was therefore trans-
formed (loge). We also converted the transformed night time cortisol, diurnal drop and CAR to study- specific 
z-scores.
The crystallised ability measures (GIT, Mill Hill Vocabulary test and NART) were standardised by computing 
study-specific z-scores to take into account protocol variability. For each cohort, fluid ability was derived by per-
forming factor analysis on the three fluid cognition measures in CaPS (Animal naming, AH4 and reaction time), 
LASA (Coding Task, RCPM and verbal memory), NCDS (Animal naming, letter cancellation and immediate 
memory), NSHD (Reaction time, verbal memory and letter cancellation) and WHII (Animal naming, AH4 and 
verbal memory). The factor analysis resulted in standardised fluid ability outcome measures (mean 0 and stand-
ard deviation 1). In the factor analysis we specified that the principle component factor method be used so that 
communalities are assumed to be 1.
We used linear regression models to analyse crystallised ability and fluid ability. We chose potential confound-
ers for the analysis from the literature (age64, sex64, adiposity64, smoking status65 and socioeconomic position66). 
We adjusted the final multivariable model for age, sex, body mass index (BMI) (Kg/m2), smoking status (never, 
past or current) and socioeconomic position (higher, lower).
We undertook a two stage meta-analysis of individual participant data with each model initially run within 
each cohort (the first stage) for CaPS, LASA, NSHD and WHII. The cohort- specific effect estimates and standard 
errors were then pooled by running random-effects meta-analysis using the DerSimonian and Laird method67. 
For the second stage, the co-authors from NCDS completed a standardised table with specific effect estimates 
and standard errors. We initially adjusted these analyses for age and sex and then additionally for BMI, smok-
ing status and SEP as potential covariates that may confound the association. We investigated between study 
heterogeneity using I2 statistic68. We examined potential sources of heterogeneity for age (above versus below 
median age), sex, adiposity (BMI at ≥30Kg/m2 versus <30Kg/m2 for obese and non-obese participants), smok-
ing status (current smoker versus non-smoker) and SEP (higher versus lower SEP) by stratifying random-effects 
meta-analyses by each of these factors and by running meta-regression analyses69. For meta-regression analyses, 
we used post-estimation Wald tests to obtain F ratios and p values.
sensitivity analysis. We ran a fixed-effect meta-analysis using the Mantel-Haenszel method70 and compared 
the results with the random-effects meta-analysis. Due to differences in the methodology for calculating diurnal 
drop in NCDS, we repeated the meta-analysis for the associations between diurnal drop and fluid ability, but omit-
ting the NCDS cohort data. Due to the difference of the measurements of cortisol in LASA (serum cortisol in LASA 
and salivary cortisol in the other cohorts), we repeated the meta-analyses for the associations between morning cor-
tisol and i) crystallised ability and ii) fluid ability, but omitting the LASA cohort data. Since the DerSimonian-Laird 
estimator may underestimate the between-study heterogeneity71, we ran a Restricted Maximum Likelihood (REML) 
method and compared the results with the DerSimonian-Laird random-effects method.
Data Availability
All requests for collaboration on the Caerphilly Prospective Study are reviewed by an independent steering com-
mittee (http://www.bris.ac.uk/social-community-medicine/projects/caerphilly/collaboration/). MRC National 
Survey of Health and Development data used in this publication are available to bona fide researchers upon re-
quest to the NSHD Data Sharing Committee via a standard application procedure. Further details can be found at 
http://www.nshd.mrc.ac.uk/data. doi: 10.5522/NSHD/Q101; doi:10.5522/NSHD/Q102. National Child Develop-
ment Study data are available via registration with the UK Data Service. Data from the Longitudinal Aging Study 
Amsterdam (LASA) are available for use for specific research questions, provided that an agreement is made up. 
Research proposals should be submitted to the LASA Steering Group, using a standard analysis proposal form 
that can be obtained from the LASA website: www.lasa-vu.nl. Files with data published in this publication are 
freely available for replication purposes and can be obtained using the same analysis proposal form. The LASA 
Steering Group will review all requests for data to ensure that proposals for the use of LASA data do not violate 
privacy regulations and are in keeping with informed consent that is provided by all LASA participants. Whitehall 
II data, protocols, and other metadata are available to the scientific community. Please refer to the Whitehall II 
data sharing policy at https://www.ucl.ac.uk/whitehallII/data-sharing.
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